The healthcare company’s revised earnings projections are likely to add to investor uncertainty about the Medicare Advantage business.
CVS Health Cuts 2024 Guidance Due to Higher Medical Costs
The healthcare company’s revised earnings projections are likely to add to investor uncertainty about the Medicare Advantage business.
